Aptorum Group Limited (NASDAQ:APM) Short Interest Down 57.4% in January

Aptorum Group Limited (NASDAQ:APM) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 78,800 shares, a decline of 57.4% from the December 31st total of 184,800 shares. Based on an average daily volume of 2,220,000 shares, the short-interest ratio is presently 0.0 days. Currently, 2.0% of the company’s stock are sold short.

Aptorum Group Stock Performance

Shares of APM traded up $0.12 during midday trading on Thursday, hitting $1.24. 59,400 shares of the company’s stock traded hands, compared to its average volume of 1,060,605. Aptorum Group has a 1 year low of $0.46 and a 1 year high of $17.49. The firm’s fifty day moving average is $1.10 and its 200-day moving average is $1.93.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.